Institutional investors purchased a net $217.5 thousand shares of ABIO during the quarter ended June 2017 and now own 32.01% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 1.3 Thousand shares of ARCA Biopharma Inc
CREATIVE PLANNING, INC. Sold 9.00 shares of ARCA Biopharma Inc